4 In neurones which possess Transport-P, transfection with a 1b adrenoceptor cDNA resulted in over-expression of a 1B adrenoceptors, but the prazosin paradox was unaltered. Thus, a 1 adrenoceptors and Transport-P mediate distinct functions in peptidergic neurones.
Introduction
Classically, a radiolabelled ligand binds to its receptor and can be displaced by added unlabelled ligand in a simple equilibrium process. When the a 1 adrenergic ligand [ 3 H]-prazosin binds to peptidergic neurones it is displaceable by unlabelled prazosin in concentrations up to 10 77 M. However, at greater concentrations of unlabelled prazosin, there is a paradoxical increase in the binding of [ 3 H]-prazosin (AlDamluji & Krsmanovic, 1992; Al-Damluji et al., 1993 ; Figure  1 ). The following hypothesis was formulated to explain these ®ndings:
(1) One component of the interaction with [ 3 H]-prazosin is its normal equilibrium with a 1 adrenoceptors on the peptidergic neurones. This equilibrium is the dominant process at lower concentrations of added unlabelled prazosin. Thus, the observed anity at lower concentrations of prazosin for the binding sites is similar to its anity for a 1 adrenoceptors expressed in cultured cells transfected with a 1 adrenoceptor cDNA (Al-Damluji & Kopin, 1996a) .
(2) The paradoxical increase in [ cells or storage organelles ; (c) the prazosin paradox is an energy-dependent process, the source of energy being the electrochemical proton gradient which is generated by vacuolar-type ATPase (V-ATPase; Al-Damluji & Kopin, 1996a) ; (d) ligands for Transport-P must possess a speci®c chemical structure, consisting of a hydrophobic phenyl group, an alkyl side chain and a basic amine (Al-Damluji & Kopin, 1998) ; (e) a¯uorescent analogue of prazosin accumulated in intracellular vesicles, providing visual evidence for uptake ; (f) following accumulation by Transport-P, the amines can be released by an energy-dependent process (Shen & Al-Damluji, 1997 ).
We have now tested the ®rst part of the hypothesis by examining gonadotrophin-releasing hormone (GnRH) peptidergic neurones, which express Transport-P, for the presence of RNA encoding a 1 adrenoceptors. Three sub-types of a 1 adrenoceptors have been de®ned in native tissues and by DNA cloning; the native receptors are now designated a 1A , a 1B and a 1D and the corresponding cDNA clones are now designated a 1a , a 1b and a 1d (Hieble et al., 1995) . All three subtypes are present in the nervous system and at all three, prazosin is an antagonist with pA 2 values of 9 ± 10 (Lomasney et al., 1991) . Hence, all three subtypes are candidates for an interaction with Transport-P.
We have tested the possibility that the prazosin paradox may be due to internalization of ligand-receptor complexes and we have examined the possible interaction of the relevant a 1 adrenoceptor sub-type with Transport-P. Our ®ndings indicate that the prazosin paradox is not a function of a 1 adrenoceptors, and that Transport-P and a 1 adrenoceptors mediate distinct functions in peptidergic neurones. Transport-P is likely to be encoded by an unusual transporter molecule which accumulates amines in peptidergic neurones.
Methods

Cell culture
Immortalized gonadotrophin-releasing hormone (GnRH) neurones (GT1-1 cells; Mellon et al., 1990) , immortalized noradrenergic neurones (SK-N-SH neuroblastoma cells; Biedler et al., 1973) , DDT 1 MF-2 smooth muscle cells (Cornett & Norris, 1982) , and COS-7 kidney cells (Gluzman, 1981) were cultured as previously described in detail (AlDamluji et al., 1993) . Brie¯y, the cells were grown in Corning 75 cm 2 or 150 cm 2¯a sks in culture medium consisting of Dulbecco's modi®ed Eagle's medium (DMEM) and Ham's F-12 (ratio 1 : 1) containing 10% fetal bovine serum (FBS) and sodium bicarbonate 3.7 g/l, in a humidi®ed atmosphere containing 5% CO 2 in air. Culture media were changed at 48 h intervals. When the cells reached con¯uence, they were dispersed in the presence of trypsin, deoxyribonuclease I (DNAseI) and ethylenediaminetetraacetic acid (EDTA) and incubated in Corning 12-well plates (2610 6 cells/well) for uptake and binding studies.
Uptake and binding studies
Uptake and binding studies were performed on intact cells which were grown in 12-well plates coated with poly-D-lysine (2.5 mg cm 2 ; Sigma P-6407; MW 70,000 ± 150,000) and laminin (0.25 mg cm 2 ; Sigma L-2020). Culture media were changed at 48 h intervals. Drugs were dissolved in buer consisting of DMEM with 25 mM HEPES and 0.5 mM sodium ascorbate, pH 7.4. After 4 days in culture, the cells were washed twice with buer at 258C then incubated at 378C or at 08C for 60 min in the presence of [ At the end of the incubation period, the buer was removed and the culture plates were placed on ice to inhibit the release of amines (Shen & Al-Damluji, 1997) . The cells were then washed twice with buer at 08C. The buer was then removed and the cells were solubilized with 2 ml of a warm solution of 0.1% sodium dodecyl sulphate and 0.1 M sodium hydroxide. Fifty microlitre aliquots were removed for protein assay and 10 ml of scintillation liquid was then added to the cell extract, mixed and radioactivity was measured in a scintillation spectrometer with an eciency of 50%. Protein content was measured by the bicinchoninic acid modi®cation of the biuret reaction (Smith et al., 1985) H]-noradrenaline, and as moles prazosin or noradrenaline (labelled and unlabelled), by accounting for the fall in speci®c activity of the radioligands consequent upon isotope dilution. Non-speci®c uptake was de®ned as the amount of cellular prazosin or noradrenaline accumulated at 08C. Speci®c uptake was obtained by subtracting non-speci®c uptake from total uptake. Each experimental point was carried out in triplicate and each experiment was replicated at least once. The minimum number of estimations for each experimental point was therefore six. The data are expressed as the means+s.e.mean. Standard error bars are not shown where they are smaller than the sizes of the symbols. Half-maximal inhibitory concentrations (IC 50 ) values were calculated from concentration-response curves. The anity constant (K D praz ) of prazosin for a 1 adrenoceptor binding sites was calculated from plots of bound vs bound/free ligand, in which the gradient=71/K D (Scatchard, 1949) . The anities of other ligands were calculated using the equation: (Cheng & Pruso, 1973) .
Preparation of RNA and cDNA library from GnRH neurones
Preparation of total cellular RNA and poly(A) + RNA was based on previously described procedures with minor modi®cations (Aviv & Leder, 1972; Glisin et al., 1974; Chirgwin et al., 1979; Okayama et al., 1987) . Brie¯y, GT1-1 GnRH cells were grown in Falcon 150 mm dishes (3610 7 cells/dish). After 10 days, the cells were washed with PBS then disrupted in`GTC solution' (5.5 M guanidinium thiocyanate, 25 mM sodium citrate and 0.5% lauryl sarcosine, pH 7.0) with 0.2 M 2-mercaptoethanol in DEPC-treated water. The viscous cell lysate was sheared with a Polytron then overlayed on a caesium TFA cushion (Pharmacia; density 1.51 g ml
71
) and centrifuged at 25,000 r.p.m. for 26 h at 158C. The pellet was redissolved in`GTC solution' and the RNA was precipitated with acetic acid and ethanol, then washed with 70% ethanol. Two more precipitation cycles with salt and ethanol were carried out to remove any remaining salts and the RNA was dissolved in TE buer. RNA quality was tested by fractionation in a denaturing 1.2% agarose gel followed by visualization of ribosomal bands in u.v. light. Poly(A) + RNA was isolated on an oligo(dT)-cellulose column (Collaborative Biomedical Products) followed by elution in a low salt buer.
Using poly(A) + RNA from the GnRH cells, a size-selected, directional cDNA library was constructed in the pSVSPORT1 vector, using the GIBCO BRL Superscript kit with modi®cations. Brie¯y, the ®rst cDNA strand was synthesized using 5 mg poly(A) + RNA, oligo(dT)-NotI primer-adapter (1 mg) and Superscript II reverse transcriptase (1000 units). The RNA was degraded and the second strand was synthesized by simultaneous addition of E. coli RNAse H, E. coli DNA polymerase and E. coli DNA ligase. A SalI/ XhoI cohesive adapter was ligated to the 5' end of the cDNA and the oligo(dT)-NotI primer-adapter at the 3' end was digested with NotI to reveal the cohesive site. The cDNA was then fractionated in 0.8% agarose without ethidium bromide and DNA greater than 1000 bp was extracted from the gel using a Qiaex kit (Qiagen). The cDNA was then ligated to pSVSPORT1 which had been digested with NotI and SalI. The ligate was introduced into E. coli strain MC 1061 (BioRad) by electroporation using a Bio-Rad GenePulser set at the following parameters: 2.5 kV; 25 uF; 200 ohms. The ratio of cDNA : plasmid in the ligation reaction was optimized to achieve the maximum number of transformants. Two million transformed bacteria were grown at 378C in a shaking incubator for 1 h then transferred to a semi-solid medium (FMC Sea-Prep agarose 3 g in 1 litre of 26LB medium with ampicillin 50 mg ml
) and ampli®ed by overnight growth in a static incubator. The semi-solid medium ensures representative ampli®cation of the clones (Kriegler, 1991) . The ampli®ed bacteria were recovered from the semi-solid medium by centrifugation and divided into aliquots which were stored in liquid nitrogen. DNA was extracted from one of the aliquots using a Qiagen Maxiprep kit. Twenty colonies were picked at random and grown overnight in LB/ ampicillin. Plasmid DNA was extracted, digested to separate the plasmid from the insert, then run in 0.8% agarose and cDNA insert sizes calculated. Analysis of 20 randomly selected clones indicated that average insert size was 1493+213 bp.
Polymerase chain reactions, cloning and DNA sequence analysis PCR primers were designed using the MacVector sequence analysis software. The following primer pairs were derived from regions which are homologous in the sequence of the cloned alpha-1 adrenergic receptors: A1BF2 upstream primer (ATCTTGGTCATCCTGTCGGTGG) and AIBB9 downstream primer (TGAAGAAGGGGAGCCAACATAAG); A1BF1 upstream primer (GAAATGTCCAACTCCAAG-GAGCTGACCCTGAG) and AIBB1 downstream primer (CCAAGGTTTTGGCTGCTTTCTTTTCCCTGG); A1BF4 upstream primer (TCACCGAAGAACCCTTCTACGC) and A1BB4 downstream primer (TGTCATCCAGAGAGTCC-TTCCG); A1BF5 upstream primer (AAATGAATCCC-GATCTGGACACCG) and A1BB5 downstream primer (TCAATGGAGATGGCACATAGGCTC).
The PCR template was either GnRH cell total cellular RNA or the GnRH cell cDNA library. For RNA PCR, the reverse transcription reaction consisted of 250 ng RNA, A1BB9 downstream primer (0.2 mM), rTth DNA polymerase/reverse transcriptase (Perkin Elmer; 5 units), dNTPs (200 mM each), MnCl 2 (1 mM) and reverse transcription buer (16) to a total volume of 20 ml. Reverse transcription was carried out in the thermal cycler at 608C for 15 min. The reaction product was then ampli®ed by adding to the reaction tube chelating buer (Perkin Elmer) to 0.86, MgCl 2 (2.5 mM) and A1BF2 upstream primer (0.2 mM) to a total volume of 100 ml. Cycling parameters were as follows: 958C for 1 min then 958C for 10 s (denaturing) and 658C for 15 s (annealing and extension); 35 cycles, followed by ®nal extension at 658C for 7 min. This ®rst PCR was followed by a second ampli®cation using the nested primer pair A1BF1/A1BB1 (0.2 mM each primer), 10 ml of the product of the ®rst ampli®cation as template, PCR buer (Perkin Elmer; 16; MgCl 2 1.5 mM), dNTPs (200 mM each) and AmpliTaq Gold DNA polymerse (Perkin Elmer; 2.5 units) to a ®nal volume of 75 ml. This second ampli®cation utilized Ampliwax (Perkin Elmer) in a`hot start' technique, as recommended by the manufacturer. Cycling parameters were as follows: 958C for 12 min to activate AmpliTaq Gold then 958C for 30 s (denaturing), 658C for 30 s (annealing) and 728C for 1 min (extension); 35 cycles. Controls included reactions in which either a primer or the template were excluded. The reaction products were analysed in an ethidium bromide-stained agarose gel.
In the PCRs which used the cDNA library as template, the reactions which used the A1BF4/A1BB4 and A1BF5/ A1BB5 primer pairs consisted of PCR buer (Perkin Elmer; 16; MgCl 2 1.5 mM), dNTPs (200 mM each), primers (1 mM each), AmpliTaq Gold DNA polymerse (Perkin Elmer; 2.5 units) and template (0.5 mg) to a ®nal volume of 75 ml. These reactions were carried out as`hot start' using Ampliwax. Cycling parameters were as follows: 958C for 12 min then 958C for 30 s (denaturing), 598C for 30 s (annealing) and 728C for 1 min (extension); 30 cycles. The reactions which used the A1BF2/A1BB9 primer pair were identical to the above except that the reaction buer was PCR buer II (Perkin Elmer; 16) with MgCl 2 2.5 mM and the annealing temperature was 658C. Controls included reactions in which either a primer or the template were excluded. The reactions were analysed in agarose gels.
The reaction products were cloned using the TA technique. Brie¯y, PCR products were generated using the optimized conditions described above, except that the reactions included a ®nal extension step of 728C for 10 min to increase the likelihood of addition of 3' adenosines by Taq polymerase. Immediately after the end of the reactions, 2 pmoles of reaction product was combined with 20 fmoles of the TA cloning vectors pCR2.1 or pCR3.1 (Invitrogen), T4 DNA ligase (4 Weiss units) and ligation buer (Invitrogen; 16) to a ®nal volume of 10 ml and incubated overnight at 148C. The ligation reaction was then used to transform competent E. coli strains INV-a F' or TOP10F' (Invitrogen) by heat shock according to the suppliers' protocol. The bacteria were grown overnight on LB agar plates with kanamycin 50 mg ml 71 . Individual colonies were picked, ampli®ed by overnight growth in liquid LB medium with kanamycin (50 mg ml 71 ) and the plasmid DNA was then extracted using Qiagen miniprep kits. An aliquot of each miniprep DNA was subjected to PCR using the primers and reaction conditions which were used to generate the product (see above) to con®rm the correct identity of the inserts in the cloning vectors.
PCR products which had been correctly ligated to the cloning vectors were sequenced either using an automated ABI sequencer or manually. The latter employed the dsDNA Cycle Sequencing System (Life Technologies) in which a sequencing primer (1 pmole) was labelled with 33 P using T4 polynucleotide kinase (1 unit) in a 5 ml reaction. The labelled primer was then used in a cycle sequencing reaction which employed 200 ng of template and 1.25 units of Taq polymerase. Cycling parameters were: 958C for 30 s (denaturing), 558C for 30 s (annealing) and 728C for 1 min (extension); 30 cycles. The reaction products were then electrophoresed in a 6% polyacrylamide gel and autoradiographed using Kodak MR-2 ®lm. Sequences were assembled and analysed using the AssemblyLign and MacVector sequence analysis software (Oxford Molecular Group). At least two clones were sequenced from each PCR product, in order to ensure accuracy of the data.
Expression of cDNA in mammalian cells
COS-7 cells or GnRH neurones were grown in Nunc 175 cm 2¯a sks (approximately 2610 7 cells/¯ask) for 2 ± 4 days and culture media were changed at 48 h intervals. The cells were then dispersed in the presence of trypsin, DNAseI and EDTA and washed twice in 10 ml culture medium. The cells were then concentrated to a density of 10 8 cells ml 71 of culture medium. An aliquot of the cell suspension (250 ml; 2.5610 7 cells) was placed in Bio-Rad cuvettes (inter-electrode distance 0.4 cm) and 10 mg of plasmid DNA dissolved in TE buer (1 mg ml 71 ) was added. In control experiments, TE buer without DNA was added. The suspension was then mixed and electroporated at room temperature in a Bio-Rad Gene Pulser II device with a Capacitance Extender Plus and Pulse Controller Plus. Electroporation parameters were set as follows: GnRH neurones: 190 V, 1000 mF; COS-7 cells; 170 V, 950 mF. After 60 s, culture medium was added to the cuvette and the cell suspension was transferred to a total of 50 ml culture medium (0.5610 6 electroporated cells ml 71 ). The cells were then incubated in 12-well culture plates (2 ml well 71 ) which had been coated with poly-Dlysine and laminin. The cells were grown at 378C in the presence of 5% CO 2 in air. Binding studies were carried out 2 days after electroporation using the methods described above.
Materials
Immortalized GT1-1 GnRH neuronal cells (Mellon et al., 1990) H label in ring positions 2, 5 and 6). Unlabelled compounds and culture media were from Sigma-Aldrich (Poole, Dorset, U.K.). Syrian hamster a 1b adrenoceptor cDNA in the expression vector pBC was generously provided by Dr R.J. Lefkowitz (Cotecchia et al., 1988) . Reagents for protein assay were from Pierce & Warriner (Chester, Cheshire, U.K.).
Results
Accumulation of prazosin in GnRH peptidergic neurones; comparison to the accumulation of noradrenaline in noradrenergic neurones indicating that it represented non-speci®c accumulation. Hence, in these experiments, non-speci®c uptake was de®ned as uptake at 08C. Speci®c uptake was obtained by subtracting non-speci®c uptake from total uptake. At concentrations of prazosin greater than 10 77 M, the speci®c accumulation of prazosin was non-linear ( Figure 1) . SK-N-SH noradrenergic neurones are known to possess the pre-synaptic re-uptake process for noradrenaline (Uptake 1 ; Pacholczyk et al., 1991; Al-Damluji & Kopin, 1996a (Figure 2 ). At 08C, accumulation of noradrenaline was less than at 378C (B 0 214+23 d.p.m./well vs 3832+73 d.p.m./well). Accumulation of noradrenaline in the noradrenergic neurones at 08C was linear with concentration throughout, indicating that it represented non-speci®c accumulation. The concentration-dependance of speci®c accumulation of noradrenaline was hyperbolic and tended towards saturation at concentrations of noradrenaline greater than 10 77 M (Figure 2 ).
Molecular identification of a 1B adrenoceptors in GnRH neurones
The PCR primers were derived from the regions of the coding sequence which were homologous between the three cloned subtypes of a 1 adrenoceptors. Using GnRH neurone RNA as template, it was possible to detect a PCR product of the appropriate size in reactions which used the A1BF2/ A1BB9 primer pair in a ®rst PCR, followed by the A1BF1/ A1BB1 nested primer pair in a second PCR (Figure 3) . Further, using the GnRH neurone cDNA library as template, it was possible to detect PCR products of the appropriate sizes in reactions which used the A1BF2/A1BB9, A1BF4/ A1BB4 and A1BF5/A1BB5 primer pairs (Figure 3) . Analysis of the translated sequences of these three PCR products indicated that the sequences were 99.2% identical to the translated sequence of the mouse a 1B adrenoceptor (GenBank accession number Y12738). GT1-1 is a mouse cell line. The mouse, rat and human a 1B adrenergic receptor genes contain a large intron whose splice site is in the sixth transmembrane domain (Ramarao et al., 1992; Gao & Kunos, 1993; Zuscik et al., 1999) . This splice site is¯anked by the A1BF4/A1BB4 PCR primer pair. The sequence of the PCR product which was generated by this primer pair contained no intronic sequences, demonstrating that the reactions ampli®ed mRNA rather than contaminating genomic DNA. Figure 3 The products (shown by arrows) of polymerase chain reactions, using as templates reverse-transcribed (RT) RNA from GnRH neurones or a cDNA library which we constructed from these GnRH neurones. The primers used are described in the text. In (A) (RT-RNA as template), the ®rst PCR employed the A1BF2/A1BB9 primer pair and this was followed by a second PCR which employed the nested primer pair A1BF1/A1BB1. In (B ± D) the template was the cDNA library. The primers were A1BF2/A1BB9 in lane B, A1BF4/A1BB4 in lane C and A1BF5/A1BB5 in lane D. Speci®c products of the predicted sizes were detected in all these reactions. Size markers are shown in parallel lanes in each panel. (Figure 4A ). In these experiments, non-speci®c binding was de®ned as the amount of prazosin accumulated in control cells which had been electroporated in the absence of DNA. Speci®c binding of prazosin to COS-7 cells which had been transfected with a 1b adrenoceptor cDNA reached saturation at approximately 10 78 M.
Binding of prazosin in DDT 1 MF-2 cells, SK-N-SH cells and COS-7 cells
In DDT 1 MF-2 smooth muscle cells which are known to express native a 1B adrenoceptors, [ Figure 5A ). At greater concentrations of unlabelled prazosin, the binding of 
Discussion
Possible relationship of the prazosin paradox to a 1 adrenoceptors
In previous work, we had demonstrated that immortalized GnRH neurones possess a 1 adrenoceptors, as indicated by binding of prazosin and its displacement by unlabelled . Those binding studies were carried out in the presence of the antidepressant desipramine, in order to inhibit the accumulation of prazosin via Transport-P. In the present work, we con®rm that these neurones express an a 1 adrenoceptor gene and we identify its molecular sub-type as being a 1B . The presence of these receptors in GnRH neurones is sucient to account for the displacement of [ 3 H]-prazosin by unlabelled prazosin in the concentration range 10 79 to 10 77 M. However, a simple binding process at these receptors would obviously not explain the paradoxical increase above that concentration range. We therefore investigated the possibility that this prazosin paradox in peptidergic neurones may be due to some post-binding event at a 1 adrenoceptors, such as internalization of ligand-receptor complexes. COS-7 cells transfected with a 1b adrenoceptor cDNA expressed abundant a 1B adrenoceptors, as indicated by the great increase in [ 3 H]-prazosin binding. However, there was no prazosin paradox in these transfected cells; the accumulation of prazosin was in accord with simple equilibrium and reached saturation at approximately 10 78 M ( Figure 4A ). It therefore seemed unlikely that the prazosin paradox is due to some function of a 1 adrenoceptors. Nevertheless, the a 1B adrenoceptors in these COS-7 cells were not in a native environment; we therefore studied DDT 1 MF-2 cells which express native a 1B adrenoceptors and which are known to internalize these receptors upon exposure to the agonists adrenaline, noradrenaline and phenylephrine (Cornett & Norris, 1982; Fratelli & DeBlasi, 1987; Cotecchia et al., 1988) . As in the transfected COS-7 cells, there was no prazosin paradox in DDT 1 MF-2 cells ( Figure 4B ). In any case, receptor internalization seemed an unlikely explanation since prazosin is an a 1 adrenoceptor antagonist but internalization of ligand-receptor complexes usually follows binding of an agonist to its receptor. We therefore examined the eects of a series of adrenergic agonists which included both the endogenous non-selective neurotransmitters adrenaline and noradrenaline, and synthetic selective agonists. All these agonists displaced [ 3 H]-prazosin from a 1B adrenoceptors in DDT 1 MF-2 cells, but the prazosin paradox was not seen in any of these experiments. We conclude that receptor internalization is not a factor in our experiments.
The prazosin paradox is unaffected by an increase in a 1 adrenoceptors
The prazosin paradox was observed in peptidergic neurones but DDT 1 MF-2 are smooth muscle cells which may not possess the specialized neuronal components which are required for function of neuronal receptors. We therefore over-expressed a 1B adrenoceptors in the GnRH peptidergic neurones, to see if this would enhance the prazosin paradox in these neurones. However, the prazosin paradox was unaected by over-expression of a 1B adrenoceptors, indicating that it is mediated by a dierent component of the GnRH neurones ( Figure 5A ). From all of the foregoing, we conclude that the prazosin paradox is unlikely to be due to some function of a 1 adrenoceptors. The paradoxical increase in binding of [ 3 H]-prazosin in the presence of greater concentrations of unlabelled prazosin is likely to be due, instead, to an unusual uptake process whose functional properties are distinct from those of a 1 adrenoceptors. Further, the structural properties of ligands for Transport-P are dierent from those of ligands for a 1 adrenoceptors (Al-Damluji & Kopin, 1998) .
Possible role of a 2 adrenoceptors
In our previous work on GT1-1 cells, we were unable to detect the presence of a 2 adrenoceptor binding sites using the ligand [ 3 H]-idazoxan (RX781094; Al-Damluji et al., 1993) . However, Lee et al. (1995) subsequently used another ligand, RX821002, and demonstrated the presence of a 2A binding sites in a related cell line, GT1-7 cells. They corroborated the ®nding by demonstrating RNA and immunoreactivity which is appropriate for a 2A adrenergic receptors in the GT1-7 cells. At this stage, it is unclear whether these apparent dierences are due to technical factors or to some genuine dierence between the GT1-1 and the GT1-7 cells; in the mouse and rat brain, many cells which are immunoreactive to GnRH do not possess a 2A adrenoceptors (Lee et al., 1995) . It is therefore possible that the GT1-1 and the GT1-7 cell lines may have been derived from subsets of GnRH neurones which dier in the expression of a 2 adrenoceptors. In any case, presence of a 2 adrenoceptors does not account for the functional properties of Transport-P for the following reasons: (a) The structural properties of ligands for Transport-P are dierent from the properties of ligands for a 2 adrenoceptors (AlDamluji & Kopin, 1998) ; (b) The a 2 adrenergic agonist (Nichols & Ruolo, 1991) .
Functional properties of Transport-P
The present work includes a new analysis of the uptake of prazosin in GnRH neurones (Figure 1 ). Transport-P accumulates prazosin when this ligand is present in concentrations of 10 710 M, as evidenced by blockade of the accumulation of prazosin by lowering the temperature (Figure 1 ) and by desipramine . Accumulation of prazosin in peptidergic neurones is linear up to 10
77 M but at greater concentrations of prazosin, uptake increases in a non-linear manner, i.e., out of proportion to the increase in the extracellular concentration of prazosin (Figure 1 ). This indicates that the uptake process is being activated. This property of Transport-P has not been described for any other membrane transport system. The activation of uptake may be due to positive co-operativity of prazosin molecules which may bind to more than one site in the transporter molecule. The activation has characteristics of an energy-dependent process; the paradoxical increase is abolished at 08C, at which temperature the accumulation of prazosin is linear with concentration up to 10 76 M, indicating that it is non-speci®c. A feasible source of energy for the activation is the electrochemical proton gradient which is generated by V-ATPase; accumulation of prazosin at 10 76 M is inhibited by the organic base chloroquine, by the carboxylic ionophore monensin, by the V-ATPase inhibitor ba®lomycinA1 and by increasing extracellular pH (AlDamluji & Kopin, 1996a) . As these pharmacological manoeuvres increase intracellular pH by dierent mechanisms, their inhibitory eect on the accumulation of prazosin in peptidergic neurones indicates that Transport-P is dependent on intracellular acidity which is generated by VATPase. Further, following accumulation by Transport-P, retention of the amines in peptidergic neurones requires maintenance of intracellular acidity (Shen & Al-Damluji, 1997) . A microscopic method for detection of Transport-P revealed that a¯uorescent analogue of prazosin accumulated in peptidergic neurones in a granular distribution and that this process could be inhibited by chloroquine . This indicated that these amines accumulate in acidi®ed intracellular vesicles.
In the present study, cooling the cells to 08C was used as an experimental control, in order to inhibit uptake without aecting binding to the a 1 adrenoceptors ( Figure 1B) . The same experimental control was used to study the uptake of noradrenaline in noradrenergic neurones (Figure 2) , in order to enable comparison of Transport-P in peptidergic neurones to Uptake 1 in noradrenergic neurones. The results distinguish Transport-P from Uptake 1 ; in noradrenergic neurones, there was no increase in the accumulation of [ 3 H]-noradrenaline in the presence of concentrations of unlabelled noradrenaline greater than 10 77 M. Uptake of noradrenaline is linear up to 10 77 M and begins to saturate at greater concentrations of the amine (Figure 2) . Further, we found no evidence for speci®c accumulation of prazosin in the noradrenergic neurones ( Figure 4B ), which further distinguishes Transport-P from Uptake 1 . Inability to accumulate prazosin in SK-N-SH noradrenergic neurones is explicable by the presence in prazosin of phenolic methoxyl groups which inhibit Uptake 1 (Iversen, 1967) . In contrast, Transport-P is unaected by phenolic methoxyl groups (Al-Damluji & Kopin, 1998) . Nonneuronal cells such as muscle and glia possess an uptake process for amines (Uptake 2 ) which is insensitive to antidepressants and reserpine but is blocked by steroid hormones (Iversen, 1965; Russ et al., 1996) . Our studies so far suggest that Transport-P does not exist in non-neuronal cells. Thus, there was no antidepressant-blockable prazosin paradox in COS-7 kidney cells or in DDT 1 MF-2 smooth muscle cells ( Figure 4B ). Other features which distinguish Transport-P from Uptake 1 , Uptake 2 and from vesicular uptake have been discussed (Al-Damluji & Kopin, 1998) .
The absence of a desipramine-sensitive prazosin paradox in noradrenergic neurones, in kidney cells and in smooth muscle cells suggests that Transport-P is a specialized function of peptidergic neurones. The acidi®ed vesicles which accumulate amines in peptidergic neurones are therefore unlikely to be some acidi®ed compartment which exists in all mammalian cells (such as mitochondria or lysosomes), but is more likely a specialized anatomical feature of peptidergic neurones.
Significance for GnRH neurones
Under the present culture conditions, the GT1-1 GnRH cells express the a 1 adrenergic receptors at relatively low levels, possibly due to the absence of physiological factors which are known to induce the expression of a 1 adrenergic receptors, such as glucocorticoids and gonadal steroids (Sakaue & Homan, 1991; Petitti et al., 1992; Karkanias et al., 1996) . In vivo, GnRH neurones are densely innervated by noradrenergic nerve terminals which modulate reproductive function via their action on a 1 adrenoceptors in the hypothalamus (for review see Al-Damluji, 1993; Rosie et al., 1994; Le et al., 1997) . Previously, we demonstrated the existence of a 1 adrenoceptor binding sites in GnRH neurones (Al-Damluji & Krsmanovic, 1992; Al-Damluji et al., 1993) and we now identify these receptors as being of the a 1B sub-type. In the rat, GnRH neurones are located in the pre-optic area of the hypothalamus, and this part of the hypothalamus has been shown to contain a 1B adrenoceptors (Petitti et al., 1992; Karkanias et al., 1996) . The density of these a 1B adrenoceptors in the pre-optic area is modulated by gonadal steroids, suggesting that at least some of the a 1B adrenoceptors in the pre-optic area are located on GnRH neurones (Petitti et al., 1992; Karkanias et al., 1996) . Thus, the ®nding in the present study that immortalized GnRH neurones possess a 1B adrenoceptors is consistent with pharmacological evidence obtained in the native state in rat brain slices. Identi®cation of the molecular subtype of a 1 adrenoceptors in GnRH neurones should help to further future work on the molecular mechanisms of the adrenergic control of puberty and reproduction.
In conclusion, the GnRH peptidergic neurones of the hypothalamus possess a 1B adrenoceptors and an unusual uptake process for amines, designated Transport-P. Prazosin interacts with both of these neuronal components: at low concentrations, prazosin binds to the receptors and is also accumulated by Transport-P; at greater concentrations it activates Transport-P, resulting in accumulation of the amine in acidi®ed neuronal vesicles. The functional properties of the accumulation of prazosin in peptidergic neurones suggest that it is mediated by an unusual transporter molecule in these neurones.
